Affimed Nv logo

Affimed Nv Share Price Today

(NASDAQ: AFMD)

Affimed Nv share price is $1.03 & ₹89.58 as on 6 Mar 2025, 2.30 'hrs' IST

$1.03

0.05

(5.42%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Affimed Nv share price in Dollar and Rupees. Guide to invest in Affimed Nv stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Affimed Nv, along with analyst recommendations, forecasts, and comprehensive financials.

Affimed Nv share price movements

  • Today's Low: $0.96
    Today's High: $1.03

    Day's Volatility :6.8%

  • 52 Weeks Low: $0.92
    52 Weeks High: $8.95

    52 Weeks Volatility :89.72%

Affimed Nv (AFMD) Returns

PeriodAffimed NvSector (Health Care)Index (Russel 2000)
3 Months
-55.6%
3.7%
0.0%
6 Months
-72.82%
-2.8%
0.0%
1 Year
-81.93%
2.5%
0.0%
3 Years
-97.49%
12.9%
-11.6%

Affimed Nv (AFMD) Key Statistics

in dollars & INR

Previous Close
$0.977
Open
$0.99
Today's High
$1.03
Today's Low
$0.96
Market Capitalization
$16.0M
Today's Volume
$37.4K
52 Week High
$8.95
52 Week Low
$0.92
Revenue TTM
$5.6M
EBITDA
$-60.8M
Earnings Per Share (EPS)
$-4.68
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-149.49%

How to invest in Affimed Nv Stock (AFMD) from India?

It is very easy for Indian residents to invest directly in Affimed Nv from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Affimed Nv stock in both Indian Rupees (INR) and US Dollars (USD). Search for Affimed Nv or AFMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Affimed Nv or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Affimed Nv shares which would translate to 0.844 fractional shares of Affimed Nv as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Affimed Nv, in just a few clicks!

Returns in Affimed Nv (AFMD) for Indian investors in Rupees

The Affimed Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Affimed Nv investment value today

Current value as on today

₹23,019

Returns

₹76,981

(-76.98%)

Returns from Affimed Nv Stock

₹81,930 (-81.93%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Affimed Nv (AFMD)

-33%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Affimed Nv Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Affimed Nv

  • 683 Capital Management LLC

    3.99%

  • NEA Management Company, LLC

    2.70%

  • Point72 Asset Management, L.P.

    2.09%

  • Northern Trust Corp

    1.12%

  • TANG CAPITAL MANAGEMENT LLC

    0.90%

  • Vanguard Group Inc

    0.79%

Analyst Recommendation on Affimed Nv

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Affimed Nv(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
11
12
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Affimed Nv Stock (AFMD)

What analysts predicted

Upside of 1205.6%

Target:

$13.45

Current:

$1.03

Insights on Affimed Nv Stock (Ticker Symbol: AFMD)

  • Price Movement

    In the last 3 months, AFMD stock has moved down by -55.8%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 154.0K → 155.0K (in $), with an average increase of 0.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 8 quarters, -36.73M → -15.13M (in $), with an average increase of 14.1% per quarter
  • AFMD vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 148.4%
  • AFMD vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 149.1%
  • Price to Sales

    ForAFMD every $1 of sales, investors are willing to pay $2.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

AFMD Affimed Nv Financials in INR & Dollars

FY18Y/Y Change
Revenue
$27.0M
↑ 1080.85%
Net Income
$-22.2M
↓ 35.56%
Net Profit Margin
-82.06%
↑ 1421.57%
FY19Y/Y Change
Revenue
$23.8M
↓ 9.88%
Net Income
$-36.0M
↑ 66.17%
Net Profit Margin
-151.3%
↓ 69.24%
FY20Y/Y Change
Revenue
$34.5M
↑ 32.58%
Net Income
$-50.3M
↑ 27.81%
Net Profit Margin
-145.86%
↑ 5.44%
FY21Y/Y Change
Revenue
$45.6M
↑ 42.33%
Net Income
$-65.0M
↑ 39.06%
Net Profit Margin
-142.5%
↑ 3.36%
FY22Y/Y Change
Revenue
$43.8M
↑ 2.45%
Net Income
$-91.0M
↑ 49.51%
Net Profit Margin
-207.98%
↓ 65.48%
FY23Y/Y Change
Revenue
$9.0M
↓ 79.99%
Net Income
$-115.6M
↑ 23.18%
Net Profit Margin
-1.3K%
↓ 1072.24%
Q2 FY23Q/Q Change
Revenue
$1.5M
↑ 0.0%
Net Income
$-31.9M
↑ 0.0%
Net Profit Margin
-2.1K%
↑ 0.0%
Q3 FY23Q/Q Change
Revenue
$2.1M
↑ 41.15%
Net Income
$-26.0M
↓ 17.15%
Net Profit Margin
-1.2K%
↑ 873.41%
Q4 FY23Q/Q Change
Revenue
$169.1K
↓ 92.1%
Net Income
$-20.9M
↓ 21.27%
Net Profit Margin
-12.4K%
↓ 11129.63%
Q1 FY24Q/Q Change
Revenue
$154.0K
↓ 0.65%
Net Income
$-15.5M
↓ 19.42%
Net Profit Margin
-10.0K%
↑ 2337.85%
Q2 FY24Q/Q Change
Revenue
$154.0K
↑ 0.0%
Net Income
$-15.5M
↑ 0.0%
Net Profit Margin
-10.0K%
↑ 0.0%
Q3 FY24Q/Q Change
Revenue
$155.0K
↑ 0.65%
Net Income
$-15.1M
↓ 2.02%
Net Profit Margin
-9.8K%
↑ 266.02%
FY18Y/Y Change
Profit
$27.0M
↑ 1080.85%
FY19Y/Y Change
Profit
$23.8M
↓ 9.88%
FY20Y/Y Change
Profit
$34.5M
↑ 32.58%
FY21Y/Y Change
Profit
$45.6M
↑ 42.33%
FY22Y/Y Change
Profit
$43.8M
↑ 2.45%
FY23Y/Y Change
Profit
$9.0M
↓ 79.99%
Q2 FY23Q/Q Change
Profit
$1.5M
↑ 0.0%
Q3 FY23Q/Q Change
Profit
$2.1M
↑ 41.15%
Q4 FY23Q/Q Change
Profit
$169.1K
↓ 92.1%
Q1 FY24Q/Q Change
Profit
$154.0K
↓ 0.65%
Q3 FY24Q/Q Change
Profit
$155.0K
-
FY18Y/Y Change
Operating Cash Flow
$56.2M
↓ 293.5%
Investing Cash Flow
$-17.8M
↓ 293.91%
Financing Cash Flow
$23.3M
↓ 13.88%
FY19Y/Y Change
Operating Cash Flow
$-32.3M
↓ 158.77%
Investing Cash Flow
$4.8M
↓ 127.8%
Financing Cash Flow
$28.9M
↑ 27.05%
FY20Y/Y Change
Operating Cash Flow
$-23.6M
↓ 33.23%
Investing Cash Flow
$9.7M
↑ 84.47%
Financing Cash Flow
$84.2M
↑ 165.97%
FY21Y/Y Change
Operating Cash Flow
$-97.9M
↑ 346.35%
Investing Cash Flow
$-4.4M
↓ 148.09%
Financing Cash Flow
$151.0M
↑ 92.89%
Q2 FY23Q/Q Change
Operating Cash Flow
$-36.2M
↑ 0.0%
Investing Cash Flow
$-3.3K
↑ 0.0%
Financing Cash Flow
$-2.8M
↑ 0.0%
Q3 FY23Q/Q Change
Operating Cash Flow
$-19.5M
↓ 45.24%
Investing Cash Flow
$-40.0M
↑ 1248400.0%
Financing Cash Flow
$-1.7M
↓ 37.6%

Affimed Nv Technicals Summary

Sell

Neutral

Buy

Affimed Nv is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Affimed Nv (AFMD) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Affimed Nv logo
1.98%
-72.82%
-81.93%
-97.49%
-94.85%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Affimed Nv logo
NA
NA
0.0
-4.07
-1.49
-0.49
NA
1.05
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Affimed Nv logo
Buy
$16.0M
-94.85%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Affimed Nv

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany. The company's lead product candidates include AFM13 that has completed Phase 2 clinical trial for CD30-positive lymphoma, Phase Ib clinical trial for hodgkin lymphoma, and completed Phase IIb clinical study for peripheral T-cell lymphoma; AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers; and AFM28, an innate cell engager (ICE), which is in preclinical development for the treatment acute myeloid. It develops AFM32, an ICE candidate that is in preclinical development for the treatment of solid tumors. It has collaboration with Artiva Biotherapeutics to develop the combination of acimtamig and AlloNK; license and strategic collaboration agreement with Roivant Sciences Ltd. to develop and commercialize novel ICE molecules, including AFM32, in oncology; and strategic collaboration agreement with Genentech for the development of certain product candidates, which includes novel NK cell engager-based immunotherapeutics to treat multiple cancers. The company was formerly known as Affimed Therapeutics B.V. and changed its name to Affimed N.V. in October 2014. Affimed N.V. was founded in 2000 and is headquartered in Mannheim, Germany.
Organization
Affimed Nv
Employees
76
CEO
Dr. Shawn M. Leland Pharm.D., R.Ph.
Industry
Health Technology

Management People of Affimed Nv

NameTitle
Dr. Wolfgang Fischer Ph.D.
MD, COO, Chief Strategy Officer & Member of Management Board
Ms. Denise Mueller
Chief Business Officer & Member of Management Board
Dr. Andreas Harstrick M.D.
Chief Medical Officer & Member of Management Board
Dr. Shawn M. Leland Pharm.D., R.Ph.
Chief Executive Officer
Prof. Melvyn Little
Founder & Consultant
Mr. Michael Wolf
Head of Finance & Administration
Mr. Alexander Fudukidis
Head of Investor Relations & Director of Investor Relations
Mary Beth Sandin
Vice President of Marketing & Communications

Important FAQs about investing in AFMD Stock from India :

What is Affimed Nv share price today?

Affimed Nv share price today stands at $1.03, Open: $0.99 ; Previous Close: $0.98 ; High: $1.03 ; Low: $0.96 ; 52 Week High: $8.95 ; 52 Week Low: $0.92.

The stock opens at $0.99, after a previous close of $0.98. The stock reached a daily high of $1.03 and a low of $0.96, with a 52-week high of $8.95 and a 52-week low of $0.92.

Can Indians buy Affimed Nv shares?

Yes, Indians can invest in the Affimed Nv (AFMD) from India.

With INDmoney, you can buy Affimed Nv at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Affimed Nv at zero transaction cost.

How can I buy Affimed Nv shares from India?

It is very easy to buy Affimed Nv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Affimed Nv (AFMD) be purchased?

Yes, you can buy fractional shares of Affimed Nv with INDmoney app.

What are the documents required to start investing in Affimed Nv stocks?

To start investing in Affimed Nv, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Affimed Nv Stock (AFMD)?

Today’s highest price of Affimed Nv (AFMD) is $1.03.

Today’s lowest price of Affimed Nv (AFMD) is $0.96.

What is today's market capitalisation of Affimed Nv?

Today's market capitalisation of Affimed Nv AFMD is 16.0M

What is the 52 Week High and Low Range of Affimed Nv Stock (AFMD)?

  • 52 Week High

    $8.95

  • 52 Week Low

    $0.92

What are the historical returns of Affimed Nv (AFMD)?

  • 1 Month Returns

    1.98%

  • 3 Months Returns

    -72.82%

  • 1 Year Returns

    -81.93%

  • 5 Years Returns

    -94.85%

Who is the Chief Executive Officer (CEO) of Affimed Nv ?

Dr. Shawn M. Leland Pharm.D., R.Ph. is the current Chief Executive Officer (CEO) of Affimed Nv.